Direct oral anticoagulants rivaroxaban, edoxaban, and apixaban are direct factor Xa inhibitors.

Study for the Anticoagulation and ACS Exam with tailored flashcards and multiple choice questions, each featuring hints and detailed explanations. Prepare effectively and ensure success on your exam with confidence!

Multiple Choice

Direct oral anticoagulants rivaroxaban, edoxaban, and apixaban are direct factor Xa inhibitors.

Explanation:
This asks about how these oral anticoagulants work. Rivaroxaban, apixaban, and edoxaban act directly on factor Xa, binding to Xa and inhibiting its enzymatic activity. By stopping Xa, they prevent the conversion of prothrombin to thrombin, which reduces thrombin generation and clot formation. They do this directly, without needing antithrombin as a mediator, distinguishing them from indirect Xa inhibitors like fondaparinux, which work through antithrombin. It’s also helpful to note that dabigatran is a direct thrombin (factor IIa) inhibitor, not a Xa inhibitor, which is why these three are correctly described as direct factor Xa inhibitors.

This asks about how these oral anticoagulants work. Rivaroxaban, apixaban, and edoxaban act directly on factor Xa, binding to Xa and inhibiting its enzymatic activity. By stopping Xa, they prevent the conversion of prothrombin to thrombin, which reduces thrombin generation and clot formation. They do this directly, without needing antithrombin as a mediator, distinguishing them from indirect Xa inhibitors like fondaparinux, which work through antithrombin. It’s also helpful to note that dabigatran is a direct thrombin (factor IIa) inhibitor, not a Xa inhibitor, which is why these three are correctly described as direct factor Xa inhibitors.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy